Keryx Biopharma Uk started in year 2014 as Private Limited Company with registration number 08829670. The Keryx Biopharma Uk company has been functioning successfully for 10 years now and its status is active. The firm's office is based in London at Riverbank House. Postal code: EC4R 3TT.
There is a single director in the firm at the moment - John B., appointed on 5 February 2019. In addition, a secretary was appointed - Nicole H., appointed on 5 February 2019. As of 25 April 2024, there were 4 ex directors - Scott H., Brian A. and others listed below. There were no ex secretaries.
Office Address | Riverbank House |
Office Address2 | 2 Swan Lane |
Town | London |
Post code | EC4R 3TT |
Country of origin | United Kingdom |
Registration Number | 08829670 |
Date of Incorporation | Thu, 2nd Jan 2014 |
Industry | Other professional, scientific and technical activities not elsewhere classified |
End of financial Year | 31st December |
Company age | 10 years old |
Account next due date | Mon, 30th Sep 2024 (158 days left) |
Account last made up date | Sat, 31st Dec 2022 |
Next confirmation statement due date | Tue, 16th Jan 2024 (2024-01-16) |
Last confirmation statement dated | Mon, 2nd Jan 2023 |
The register of PSCs that own or have control over the company consists of 2 names. As we identified, there is Akebia Therapeutics, Inc. from Cambridge, United States. This PSC is classified as "a corporate", has 75,01-100% voting rights and has 75,01-100% shares. This PSC has 75,01-100% voting rights and has 75,01-100% shares. Another entity in the persons with significant control register is Keryx Biopharmaceuticals, Inc. that entered Boston, United States as the official address. This PSC has a legal form of "a corporate", owns 75,01-100% shares, has 75,01-100% voting rights. This PSC owns 75,01-100% shares and has 75,01-100% voting rights.
Akebia Therapeutics, Inc.
245 First Street, Cambridge, Massachusetts, 02142, United States
Legal authority | United States |
Legal form | Corporate |
Country registered | United States |
Place registered | Delaware |
Registration number | 4308099 |
Notified on | 12 December 2018 |
Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
Keryx Biopharmaceuticals, Inc.
One Marina Park Drive Twelfth Floor, Boston, MA 02210, United States
Legal authority | United States |
Legal form | Corporate |
Country registered | United States |
Place registered | Delaware |
Registration number | 2958400 |
Notified on | 6 April 2016 |
Ceased on | 12 December 2018 |
Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
Type | Category | Free download | |
---|---|---|---|
CS01 |
Confirmation statement with no updates 2024/01/02 filed on: 19th, January 2024 |
confirmation statement | Free Download (3 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy